In this section

Immunology of Infection

The Section of Immunology of Infection brings together world-leading research teams across Imperial's campuses, focused on immune responses to infection, chronic disease and autoimmunity. Alongside fundamental research on immune system function, a strong emphasis is placed on the development of novel therapeutics and vaccines for the treatment and prevention of globally important infections. Our research spans a wide range of viral, bacterial, and parasite infections. Our researchers lead scientific programs and collaborations with European, African, South American and South-East Asian partners. Our translational vaccine and therapeutic research includes a program of first in human trials through to the evaluation of vaccine efficacy trials against HIV, tuberculosis and malaria by the Human Immunology Laboratory (HIL).

Research areas and networks

A selection of the Section's key research areas and networks

Imperial Network for Vaccine Research (INVaR)
Human Immunology Lab (HIL)
Mucosal Infection and Immunity
Future Vaccine Manufacturing Research Hub
Immune determinants of susceptibility and protection from infection
Immunological regulation of infectious, inflammatory and autoimmune diseases
Mathematical and bioinformatic analysis and modelling immune function
Cell-mediated immunity and immunopathology.
B cell memory, repertoire and antibody function
The influence of co-infection on immune function, susceptibility and disease severity
Vaccine research, development and translation
Assessment of clinical vaccine trials (first in human to efficacy)

Section leadership

Professor Robin Shattock

Section Head, Immunology of Infection

Professor Shattock's studies aim to understand the mechanisms of mucosal infection and development of novel preventative strategies. The main focus of his research is the development of novel vaccine strategies against epidemic and outbreak pathogens.

Further information on Professor Shattock